SuperworthSchrodinger profit margin SDGR
Gross, operating and net profit as a share of revenue over the last twelve months, from 2019.
- Net margin, 12 months
- −21.0%
- Operating margin, 12 months
- −59.2%
- Net margin on a year earlier
- +55.2 pts
- Peer median
- 10.9%
Over the twelve months to Jun 30, 2026, Schrodinger kept −21.0% of its revenue as net profit, with an operating margin of −59.2% and a gross margin of 56.9%.
Five years earlier its net margin was −34.8%.
The median for 10 large drugmakers of a similar size is 10.9%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −40.4% | −65.2% | 55.7% |
| FY2024 | −90.2% | n/a | 63.6% |
| FY2023 | 18.8% | −81.9% | 64.9% |
| FY2022 | −82.4% | −81.1% | 55.8% |
| FY2021 | −72.8% | −80.8% | 47.6% |
| FY2020 | −22.6% | −56.4% | 58.7% |
| FY2019 | −28.7% | −45.3% | 57.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −21.0% | +55.2 pts | −59.2% | |
| Q1 FY26 | −40.6% | +42.8 pts | −64.7% | |
| Q4 FY25 | −40.4% | +49.8 pts | −65.2% | |
| Q3 FY25 | −68.5% | +23.4 pts | −66.3% | |
| Q2 FY25 | −76.2% | n/a | −81.1% | |
| Q1 FY25 | −83.4% | −7.4 pts | −83.6% | |
| Q4 FY24 | −90.2% | −109.0 pts | n/a | |
| Q3 FY24 | −91.8% | −114.0 pts | n/a | |
| Q2 FY24 | n/a | n/a | n/a | |
| Q1 FY24 | −75.9% | −83.2 pts | n/a | |
| Q4 FY23 | 18.8% | +101.2 pts | −81.9% | |
| Q3 FY23 | 22.2% | +111.8 pts | −88.5% |
Against its peers
Companies in Drug Manufacturers - General nearest Schrodinger's size, closest first, today.
| Company | Profit margin |
|---|---|
| SDGRSchrodinger | −21.0% |
| ANIPANI Pharmaceuticals | 11.1% |
| PAHCPhibro Animal Health | 6.6% |
| HRMYHarmony Biosciences | 18.9% |
| ANABAnaptysbio | n/m |
| PCRXPacira BioSciences | 2.0% |
| PBHPrestige Consumer Healthcare | 15.6% |
| OMEROmeros | n/m |
| NRIXNurix Therapeutics | 42.0% |
| AMPHAmphastar Pharmaceuticals | 10.8% |
| OGNOrganon | 3.4% |
| Peer median | 10.9% |
Where Schrodinger ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Schrodinger
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.